Home > Healthcare > Medical Devices > Implantable Devices > coronary artery bypass graft market
Get a free sample of Coronary Artery Bypass Graft Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Get a free sample of Coronary Artery Bypass Graft Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
The traditional (on-pump) CABG segment dominated the market with a 55.1% revenue share in 2023, due to its established efficacy and widespread adoption in surgical practices.
The U.S. coronary artery bypass graft market surpassed USD 3.5 billion in 2023 and is expected to grow at a 6.7% CAGR through 2032, led by favorable reimbursement policies and advanced healthcare infrastructure.
The grafts segment was valued at over USD 3.1 billion in 2023, as these are essential components in CABG procedures.
The global market for coronary artery bypass graft was reached USD 11.8 billion in 2023 and is estimated to grow at a 7.1% CAGR from 2024 to 2032, driven by the increasing prevalence of cardiovascular diseases.
Key players in the industry include Abbott Laboratories, AngioDynamics, AtriCure, B. Braun Melsungen AG, Boston Scientific, Cardinal Health, CryoLife, Edwards Lifesciences, Johnson & Johnson, LivaNova, Medline Industries, Medtronic, Nipro Corporation, Stryker Corporation, and Terumo Corporation.